Rockwell Medical (NASDAQ:RMTI) is set to announce its earnings results after the market closes on Tuesday, March 13th. Analysts expect the company to announce earnings of ($0.13) per share for the quarter.
Shares of Rockwell Medical (NASDAQ:RMTI) opened at $6.26 on Friday. Rockwell Medical has a 12-month low of $4.84 and a 12-month high of $8.98. The stock has a market cap of $335.83, a P/E ratio of -14.56 and a beta of 2.04.
A number of equities research analysts have issued reports on RMTI shares. Zacks Investment Research downgraded shares of Rockwell Medical from a “hold” rating to a “sell” rating in a research report on Wednesday, November 15th. BidaskClub upgraded shares of Rockwell Medical from a “sell” rating to a “hold” rating in a research report on Friday, December 15th. Finally, ValuEngine lowered shares of Rockwell Medical from a “sell” rating to a “strong sell” rating in a research note on Friday, February 2nd.
COPYRIGHT VIOLATION WARNING: “Rockwell Medical (RMTI) to Release Earnings on Tuesday” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States and international trademark and copyright legislation. The original version of this story can be accessed at https://www.tickerreport.com/banking-finance/3254353/rockwell-medical-rmti-to-release-earnings-on-tuesday.html.
Rockwell Medical, Inc (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process.
Receive News & Ratings for Rockwell Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical and related companies with MarketBeat.com's FREE daily email newsletter.